MicroRNA与肝病及肝纤维化相关研究
被引量:6
摘要
MicroRNA(miRNA)是转录后水平的细胞调控因子。在细胞核内,miRNA基因经由RNA聚合酶Ⅱ介导转录出含多聚腺苷酸尾(A从从)和帽子结构特征性标志的州一miRNA,后者在核酸酶Drosha的作用下被切割成70个具有茎环结构的miRNA前体(pro—miRNA),随后由转运蛋白exportin-5转运出核,再由胞质中Dicer蛋白切割为成熟的miRNA。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2011年第1期65-67,共3页
Chinese Journal of Pathology
参考文献23
-
1Barad O,Meiri E,Avniel A,et al.MicroRNA expression detected by oligonucleotide microarrays:system establishment and expression profiling in human tissues.Genome Res,2004,14(12).-2486 -2494.
-
2Altuvia Y,Landgraf P,Lithwick G,et al.Clustering and conservation patterns of human microRNAs.Nucleic Acids Res,2005,33 (8):2697-2706.
-
3黄增红,刘长梅.人肝脏特异性miR-122表达载体的构建及鉴定[J].生物工程学报,2009,25(4):587-590. 被引量:7
-
4Jopling CL.Regulation of hepatitis C virus by microRNA-122.Biochem Soc Trans,2008,36(Pt 6):1220-1223.
-
5Cheung O,Puri P,Eicken C,et al.Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.Hepatology,2008,48(6):1810-1820.
-
6Padgett KA,Lan RY,Leung PC,et al.Primary biliary cirrhosis is associated with altered hepatic micro_RNA expression.J Autoimmun,2009,32 (3-4):246-253.
-
7Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma.Cancer Res,2007,67(13):6092-6099.
-
8Song B,Wang Y,Kudo K,et al.miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.Clin Cancer Res,2008,14(24):8080-8086.
-
9Braun C.J,Zhang X,Savelyeva I,et al.p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.Cancer Res,2008,68 (24):10094-10104.
-
10Murakami Y,Aly HH,Tajima A,et al.Regulation of the hepatitis C virus genome replication by miR-199a.J Hepatol,2009,50(3):453-460.
二级参考文献14
-
1Bartel DP. microRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116 (2): 281-297.
-
2Xie X, Lu J, Kulbokas EJ, et al. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature, 2005, 434: 338-345.
-
3Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120: 15-20.
-
4Yi R, Qin Y, Macara IG, et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 2003, 17(24): 3011-3016.
-
5Jopling CL, Norman KL, Sarnow P. Positive and negativemodulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Syrup Quant Biol, 2006, 71: 369-376.
-
6Christopher S, Sullivan, Don Ganem. MicroRNA and viral infection. Mol Cell, 2005, 20(1): 3-7.
-
7Fabbri M, Ivan M, Cimmino A, et al. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther, 2007, 7: 1009-1019.
-
8Marsden PA. RNA interference as potential therapy-not so fast. N Engl J Med, 2006, 355(9): 953-954.
-
9Chang J, Nicolas E, Marks D, et al. Mir-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may down regulate the high affinity cationic amino acid transporter CAT-1. RNA Biology, 2004, 1(2): 106-113.
-
10Chang J, Guo JT, Jiang D, et al. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol, 2008, 82(23): 8215-8223.
共引文献6
-
1邢同京,徐洪涛.miRNA介导的乙型肝炎病毒与宿主相互作用及应用研究进展[J].中华临床医师杂志(电子版),2011,5(9):2688-2690.
-
2许蜜蝶,李维卿,余宏宇.MicroRNAs与慢性肝脏病变相关性的研究进展[J].第二军医大学学报,2010,31(8):896-899. 被引量:2
-
3郝美君,郑素军,丁惠国,黄爱龙.MicroRNA-122作用于HBx影响乙肝病毒复制[J].生物医学工程学杂志,2011,28(4):784-789. 被引量:7
-
4安蓬蓬.与HBV感染相关的MicroRNA研究进展[J].吉林医学,2015,36(6):1197-1198.
-
5黄可婷,吴昊,吴敏丹,马梦秋,翟旭光.小鼠pre-miRNA-122启动子荧光素酶报告质粒的构建及表达调控[J].生物技术,2017,27(3):211-217. 被引量:2
-
6李艳,罗栩伟,朱冬梅,杨姣,张英娟,张慧,陈思佳,刘刚,刘学彬.应用UTMD技术联合脂质体转染介导人肝癌细胞表达miRNA-122的研究[J].川北医学院学报,2019,34(6):667-671. 被引量:3
同被引文献67
-
1陆伦根,曾民德.肝纤维化的诊断和评估[J].中华肝脏病杂志,2005,13(8):603-604. 被引量:100
-
2孙凯,汪谦.液相芯片技术在小分子RNA检测分析中的应用[J].中华医学杂志,2006,86(20):1437-1439. 被引量:14
-
3刘厚森,唐胜球,董小英,邹晓庭.极低密度脂蛋白受体的研究[J].安徽农业科学,2006,34(13):2984-2987. 被引量:3
-
4Lee RC,Feinbaum RL,Ambros V,The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].{H}CELL,1993,(05):843-854.
-
5Zhang B,Pan X,Anderson TA. MicroRNA:a new player in stem cells[J].{H}Journal of Cellular Physiology,2006,(02):266-269.
-
6Tanno B,Cesi V,Vitali R. Silencing of endogenous IGFBP-5 by microRNA interference affects proliferation,apoptosis and differentiation of neuroblastoma cells[J].{H}Cell Death and Differentiation,2005,(03):213-223.
-
7Alvarez-Garcia I,Miska EA. MicroRNA functions in animal development and human disease[J].{H}DEVELOPMENT,2005,(21):4653-4662.
-
8Pogribny IP,Starlard-Davenport A,Tryndyak VP. Difference in expression of hepatic microRNAs miR-29c,miR-34a,miR-155,and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice[J].{H}Laboratory Investigation,2010,(10):1437-1446.
-
9Tsukamoto H,Matsuoka M,French SW. Experimental models of hepatic fibrosis:a review[J].{H}Seminars in Liver Disease,1990,(01):56-65.
-
10Jamall IS,Finelli VN,Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues[J].{H}Analytical Biochemistry,1981,(01):70-75.
引证文献6
-
1姜新民,张忠房,邵贝贝.miRNAs及其在医学领域的研究进展[J].医学检验与临床,2012,23(1):55-58.
-
2王清兰,李俊霞,吕靖,陶艳艳,闫秀川,刘成海.CCl4诱导的小鼠纤维化肝组织微小RNA差异表达谱及初步功能分析[J].中国病理生理杂志,2013,29(12):2201-2211. 被引量:8
-
3彭小芳,刘海英.循环miRNA在肝胆疾病诊断中的研究进展[J].临床肝胆病杂志,2014,30(9):965-966. 被引量:5
-
4张冰,程玉宏,刘洋,黄时顺,王志刚.极低密度脂蛋白受体在肝脏脂类代谢中的研究进展[J].医学综述,2016,22(21):4177-4182. 被引量:3
-
5李萍英,杨永耿,陆伦根,朱智勇,王亚平,马颖才.microRNA在慢性乙型肝炎肝纤维化中的诊断价值[J].临床肝胆病杂志,2017,33(12):2412-2415. 被引量:15
-
6李萍英,杨永耿,李娟,沈有秀,马颖才,陆伦根.血清EBV-miR-BART13-3P在青海地区慢性乙型肝炎肝纤维化患者中的表达及诊断价值[J].临床肝胆病杂志,2019,35(4):774-779. 被引量:2
二级引证文献33
-
1王清兰,张风,雷扬,刘成海,陶艳艳.复肝丸调控miR-424表达抑制肝窦内皮细胞血管新生的体外研究[J].上海中医药杂志,2020,54(1):68-73. 被引量:3
-
2王远懿.血清miR-122和miR-18a作为HBV相关肝病诊断标志物的可行性研究[J].晓庄学院学报(医学版),2020,17(6):48-50. 被引量:1
-
3非成瑞,李卫东.基于microRNA的抗病毒研究进展[J].国际病毒学杂志,2018,25(6):429-432.
-
4宋立莹,彭向东,王春江,郭韧,刘世坤.miRNA参与肝星状细胞活化及慢性肝病发展的作用机制研究进展[J].中国临床药理学与治疗学,2014,19(12):1422-1428. 被引量:9
-
5林坤,次旦旺久,畅智慧,刘兆玉.循环microRNAs在肝胆胰肿瘤发生发展中的作用[J].临床肝胆病杂志,2015,31(5):790-795. 被引量:2
-
6应娜,刘禹臣,钱倩宇,胡林峰,蒋福升,李松涛,窦晓兵.金花茶通过AMPK/PPAR-α通路减轻NAFLD引起的脂代谢异常机制研究[J].浙江中医药大学学报,2019,0(10):1138-1143. 被引量:5
-
7王清兰,陶艳艳,吕靖,刘平,刘成海.扶正化瘀方调节差异微小RNAs表达的抗肝纤维化的作用机制[J].临床肝胆病杂志,2016,32(3):503-508. 被引量:7
-
8徐志伟,王文栋,常晓彤.胰岛素抵抗小鼠血清微小RNA的芯片及信息学分析[J].中国病理生理杂志,2016,32(4):738-744. 被引量:4
-
9单一波,史宏灿,雷正文.循环miRNA与食管癌诊断和预后的研究进展[J].中华胸心血管外科杂志,2017,33(2):126-128. 被引量:2
-
10雷扬,陶艳艳,王清兰,罗运权,刘成海.miRNA-21/101/125a/195/200b在肝硬化、肝癌中的表达变化[J].肝脏,2017,22(4):310-313. 被引量:4
-
1叶林,宋希双.前列腺癌相关microRNA的研究进展[J].中华医学杂志,2010,90(14):1001-1003.
-
2蒲广斌,杨小迪,孙新.MicroRNA在血吸虫病致病机制中的作用[J].国际医学寄生虫病杂志,2015,42(2):109-111. 被引量:1
-
3于嘉,穆荣普.一种可用于伤寒沙门氏菌分型的新方法——rRNA基因限制性图谱法[J].国外医学(流行病学.传染病学分册),1991,18(3):100-103.
-
4程艳梅,王磊,张秀莲,朱生樑.MicroRNA与食管肿瘤的研究进展[J].实用医学杂志,2012,28(12):2095-2097. 被引量:2
-
5葛善飞,刘菲,谢建萍.miRNAs调控肝星状细胞生物学活性机制研究进展[J].山东医药,2016,56(2):101-103. 被引量:5
-
6AndrewLever,张宏伟,盛瑞媛.HIV病毒[J].国际内科双语杂志(中英文),2004,4(1):56-59. 被引量:1
-
7吕雪莲,张晓利,刘维达.医学及感染微生态研究中分子技术的应用[J].中华临床感染病杂志,2009,2(2):122-127.
-
8于冬冬,赵丹阳.葛根素通过p38MAPK通路抑制MC3T3-E1成骨细胞凋亡[J].中国现代医学杂志,2017,27(5):7-12. 被引量:11
-
9朱楠,袁伟杰.微小RNA在肾脏及其相关疾病中的调控作用[J].中华医学杂志,2010,90(44):3166-3168.
-
10黄帅,郭慧慧,王璐璐,韩燕星,蒋建东.miRNAs与肿瘤[J].中国医药生物技术,2016,11(3):267-271. 被引量:5